Regado Biosciences (RGDO) FDA Fast Track an 'Incramental Positive', BMO Capital
Tweet Send to a Friend
BMO Capital analyst Jim Birchenough, M.D. reiterated an Outperform rating and $12 price target on Regado Biosciences (NASDAQ: RGDO) after ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
